162 related articles for article (PubMed ID: 28454668)
1. Choosing Wisely? Measuring the Burden of Medications in Older Adults near the End of Life: Nationwide, Longitudinal Cohort Study.
Morin L; Vetrano DL; Rizzuto D; Calderón-Larrañaga A; Fastbom J; Johnell K
Am J Med; 2017 Aug; 130(8):927-936.e9. PubMed ID: 28454668
[TBL] [Abstract][Full Text] [Related]
2. Use of Medications of Questionable Benefit During the Last Year of Life of Older Adults With Dementia.
Morin L; Vetrano DL; Grande G; Fratiglioni L; Fastbom J; Johnell K
J Am Med Dir Assoc; 2017 Jun; 18(6):551.e1-551.e7. PubMed ID: 28431913
[TBL] [Abstract][Full Text] [Related]
3. How many older adults receive drugs of questionable clinical benefit near the end of life? A cohort study.
Morin L; Wastesson JW; Laroche ML; Fastbom J; Johnell K
Palliat Med; 2019 Sep; 33(8):1080-1090. PubMed ID: 31172885
[TBL] [Abstract][Full Text] [Related]
4. Drug Use in Older Adults with Amyotrophic Lateral Sclerosis Near the End of Life.
Grande G; Morin L; Vetrano DL; Fastbom J; Johnell K
Drugs Aging; 2017 Jul; 34(7):529-533. PubMed ID: 28536907
[TBL] [Abstract][Full Text] [Related]
5. Preventive drugs in the last year of life of older adults with cancer: Is there room for deprescribing?
Morin L; Todd A; Barclay S; Wastesson JW; Fastbom J; Johnell K
Cancer; 2019 Jul; 125(13):2309-2317. PubMed ID: 30906987
[TBL] [Abstract][Full Text] [Related]
6. The Burden of Polypharmacy in Patients Near the End of Life.
McNeil MJ; Kamal AH; Kutner JS; Ritchie CS; Abernethy AP
J Pain Symptom Manage; 2016 Feb; 51(2):178-83.e2. PubMed ID: 26432571
[TBL] [Abstract][Full Text] [Related]
7. Is the level of education associated with transitions between care settings in older adults near the end of life? A nationwide, retrospective cohort study.
Kelfve S; Wastesson J; Fors S; Johnell K; Morin L
Palliat Med; 2018 Feb; 32(2):366-375. PubMed ID: 28952874
[TBL] [Abstract][Full Text] [Related]
8. Effect of polypharmacy, potentially inappropriate medications and anticholinergic burden on clinical outcomes: a retrospective cohort study.
Lu WH; Wen YW; Chen LK; Hsiao FY
CMAJ; 2015 Mar; 187(4):E130-E137. PubMed ID: 25646290
[TBL] [Abstract][Full Text] [Related]
9. How Chronic Is Polypharmacy in Old Age? A Longitudinal Nationwide Cohort Study.
Wastesson JW; Morin L; Laroche ML; Johnell K
J Am Geriatr Soc; 2019 Mar; 67(3):455-462. PubMed ID: 30575952
[TBL] [Abstract][Full Text] [Related]
10. The composition of polypharmacy: A register-based study of Swedes aged 75 years and older.
Wastesson JW; Cedazo Minguez A; Fastbom J; Maioli S; Johnell K
PLoS One; 2018; 13(3):e0194892. PubMed ID: 29596512
[TBL] [Abstract][Full Text] [Related]
11. Institutionalization as a risk factor for inappropriate drug use in the elderly: a Swedish nationwide register-based study.
Haasum Y; Fastbom J; Johnell K
Ann Pharmacother; 2012 Mar; 46(3):339-46. PubMed ID: 22318931
[TBL] [Abstract][Full Text] [Related]
12. Medication appropriateness for patients with dementia approaching the end of their life.
Chuang HY; Wen YW; Chen LK; Hsiao FY
Geriatr Gerontol Int; 2017 Apr; 17 Suppl 1():65-74. PubMed ID: 28436189
[TBL] [Abstract][Full Text] [Related]
13. Changes in Prescribed Drugs Between Admission and the End of Life in Patients Admitted to Palliative Care Facilities.
van Nordennen RT; Lavrijsen JC; Heesterbeek MJ; Bor H; Vissers KC; Koopmans RT
J Am Med Dir Assoc; 2016 Jun; 17(6):514-8. PubMed ID: 26935532
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate medication use and polypharmacy in end-stage cancer patients: Isn't it the family doctor's role to de-prescribe much earlier?
Garfinkel D; Ilin N; Waller A; Torkan-Zilberstein A; Zilberstein N; Gueta I
Int J Clin Pract; 2018 Apr; 72(4):e13061. PubMed ID: 29359381
[TBL] [Abstract][Full Text] [Related]
15. The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.
Haider SI; Johnell K; Weitoft GR; Thorslund M; Fastbom J
J Am Geriatr Soc; 2009 Jan; 57(1):62-9. PubMed ID: 19054196
[TBL] [Abstract][Full Text] [Related]
16. Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency.
Onder G; Marengoni A; Russo P; Degli Esposti L; Fini M; Monaco A; Bonassi S; Palmer K; Marrocco W; Pozzi G; Sangiorgi D; Buda S; Marchionni N; Mammarella F; Bernabei R; Pani L; Pecorelli S; ;
J Am Med Dir Assoc; 2016 Feb; 17(2):168-72. PubMed ID: 26441359
[TBL] [Abstract][Full Text] [Related]
17. Adequate, questionable, and inadequate drug prescribing for older adults at the end of life: a European expert consensus.
Morin L; Laroche ML; Vetrano DL; Fastbom J; Johnell K
Eur J Clin Pharmacol; 2018 Oct; 74(10):1333-1342. PubMed ID: 29934849
[TBL] [Abstract][Full Text] [Related]
18. The development of polypharmacy. A longitudinal study.
Veehof L; Stewart R; Haaijer-Ruskamp F; Jong BM
Fam Pract; 2000 Jun; 17(3):261-7. PubMed ID: 10846147
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness.
Schenker Y; Park SY; Jeong K; Pruskowski J; Kavalieratos D; Resick J; Abernethy A; Kutner JS
J Gen Intern Med; 2019 Apr; 34(4):559-566. PubMed ID: 30719645
[TBL] [Abstract][Full Text] [Related]
20. Prescription of potentially inappropriate medications among older people with intellectual disability: a register study.
Axmon A; Sandberg M; Ahlström G; Midlöv P
BMC Pharmacol Toxicol; 2017 Oct; 18(1):68. PubMed ID: 29070067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
